Medical Awareness & Prevention

A Cambridge model estimates that WHO air-quality limits for PM2.5 could prevent or postpone 9.4 million deaths in 136 low- and middle-income countries in one year.

• Caregiver Information
• November 11, 2026

A South Korean study found smartwatch AI-ECG readings often disagreed across devices and over time, raising questions about screening reliability.

• Caregiver Information
• November 10, 2026

A study found that an MRI-based brain aging marker tracked blood-based aging measures in two midlife cohorts, but its predictive use remains uncertain.

• Caregiver Information
• November 10, 2026

A UK randomized trial found similar combined survival and quality-of-life outcomes for dialysis planning and conservative care in older, frail patients.

• Caregiver Information
• November 7, 2026

A study of 830,393 adults found similar dementia rates among users of anticholinergic and beta-3 agonist bladder drugs, but limits remain.

• Caregiver Information
• November 7, 2026

Two phase III trials found elafibranor and seladelpar increased ALP normalization at 52 weeks in patients with PBC and a partial response to first-line therapy.

• Caregiver Information
• November 7, 2026

RPI researchers report that Quest2Dx identified Parkinson’s-related patterns in lengthy health questionnaires, but it is a screening tool, not a diagnosis.

• Caregiver Information
• November 6, 2026

A 14-year study found heart disease was linked to faster cognitive decline, with the association varying across long-term depressive symptom patterns.

• Caregiver Information
• November 4, 2026

Researchers developed a conversation-based dementia risk score for low- and middle-income countries, with further regional validation still needed.

• Caregiver Information
• November 4, 2026

Researchers developed a conversation-based dementia risk score for older adults in seven countries, designed to support studies and trials in lower-income settings.

• Caregiver Information
• November 3, 2026